Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine and weak-opioid anesthesia in breast cancer surgery
ChiCTR2600124414Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in breast cancer and postoperative pain (2 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoint: Incidence of perioperative pain. Planned start May 2026; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
breast cancerpostoperative pain
Beyond the preview
Go deeper on ChiCTR2600124414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600124414.